Answers are grounded in this paper and cite their sources.
Faropenem was tested against 1,188 middle ear fluid pathogens from children in Israel and Costa Rica. Against Streptococcus pneumoniae and Haemophilus influenzae, faropenem was the most active beta-lactam, with activity that was similar to or greater than of the other oral antimicrobial classes studied. Faropenem was also active against Moraxella catarrhalis and Streptococcus pyogenes.
No takes yet. Share an insight, caveat, or question.
Stone et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: